Mid-Day Market Update: Crude Oil Surges Over 2%; Supernus Pharmaceuticals To Acquire Adamas Pharmaceuticals

Halfway by way of buying and selling Monday, the Dow traded up 0.50% to 34,920.55 whereas the NASDAQ rose 0.50% to 34,920.55. The S&P additionally rose, gaining 0.44% to 4,410.73.

The U.S. has the very best variety of coronavirus circumstances and deaths on the planet, reporting a complete of 45,204,370 circumstances with round 733,570 deaths. India confirmed a complete of at the very least 33,971,600 confirmed circumstances and 450,810 deaths, whereas Brazil reported over 21,575,820 COVID-19 circumstances with 601,040 deaths. In whole, there have been at the very least 238,714,960 circumstances of COVID-19 worldwide with over 4,868,700 deaths, based on information compiled by Johns Hopkins College.

Main and Lagging Sectors

Supplies shares surged 1.3% on Monday. In the meantime, high gainers within the sector included Century Aluminum Firm (NASDAQ: CENX), up 15%, and Resolute Forest Merchandise Inc. (NYSE: RFP), up 10%.

In buying and selling on Monday, utilities shares tumbled 0.6%.

Prime Headline

Supernus Prescribed drugs (NASDAQ: SUPN) agreed to accumulate Adamas Prescribed drugs (NASDAQ: ADMS) for $9.10 per share, or $450 million.
The deal consideration contains $8.10 per share in money ($400 million) and two non-tradable contingent worth rights (CVR) collectively value as much as $1.00 per share in money.

Equities Buying and selling UP

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares shot up 89% to $34.45. The FDA eliminated the total medical maintain on Protagonist Therapeutics’ rusfertide medical research. Northland Capital Markets upgraded the inventory from Market Carry out to Outperform.

Shares of Adamas Prescribed drugs, Inc. (NASDAQ: ADMS) acquired a lift, taking pictures 75% to $8.09. Supernus Prescribed drugs agreed to accumulate Adamas Prescribed drugs for $9.10 per share, or $450 million.

Flexion Therapeutics, Inc. (NASDAQ: FLXN) shares had been additionally up, gaining 61% to $9.30. Pacira BioSciences agreed to accumulate Flexion Therapeutics for $8.50 per share in money, plus one contingent worth proper (CVR) value as much as $8.00 per share in money.


Equities Buying and selling DOWN

Hyliion Holdings Corp. (NYSE: HYLN) shares tumbled 10% to $7.06 after UBS downgraded the inventory from Impartial to Promote and lowered its worth goal from $14 to $5.

Shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) had been down 12% to $4.88 after leaping round 45% on Friday.

MeaTech 3D Ltd. (NASDAQ: MITC) was down, falling 10% to $7.65. Meatech 3D not too long ago stated it’s partnering with a collective led by Ashton Kutcher and Man Oseary, along with strategic gamers like Effie Epstein, to speed up development in creating, commercializing cultured meat manufacturing applied sciences


In commodity information, oil traded up 2.3% to $81.17, whereas gold traded up 0.1% to $1,758.40.

Silver traded up 0.1% Monday to $22.73 whereas copper rose 2.5% to $4.3805.

Euro zone

European shares had been largely decrease right now. The eurozone’s STOXX 600 fell 0.02%, the Spanish Ibex Index fell 0.81%, whereas Italy’s FTSE MIB Index declined 0.58%. In the meantime, the German DAX 30 dropped 0.13%, French CAC 40 rose 0.04% and London’s FTSE 100 rose 0.53%.

Italy’s industrial manufacturing fell 0.2% from a month in the past in August versus a revised 1% development within the earlier month.


There have been no main US financial releases Monday.

© 2021 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.


Leave a Reply

Your email address will not be published. Required fields are marked *